# SYRE (Spyre Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Spyre Therapeutics, Inc. reported $0 in revenue and a net loss of $263.9M for the fiscal year ended December 31, 2025.

- Canonical: https://convexityos.com/fundamentals/SYRE
- Markdown: https://convexityos.com/fundamentals/SYRE.md
- SEC CIK: 0001636282
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:10 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001636282&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | Dec 31, 2025 |
| Operating Income | FY 2025 | -$250.2M | Operating profit |
| Net Income | FY 2025 | -$263.9M | GAAP bottom line |
| Diluted EPS | FY 2025 | -- | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.07B | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $0 | $886K | $2.33M | $18.74M | $0 | $0 | $3.89M | $5.21M | $4.63M |
| Research & Development | $171.7M | $162.8M | $89.50M | $58.58M | $57.07M | $59.64M | $64.60M | $36.72M | $22.82M | $18.14M |
| Total Operating Expenses | $209.6M | $208.6M | $243.2M | $87.11M | $84.39M | $81.48M | $80.33M | $49.35M | $32.88M | $26.53M |
| **Operating Income** | -$209.6M | -$208.6M | -$242.3M | -$84.78M | -$65.65M | -$81.48M | -$80.33M | -$45.46M | -$27.68M | -$21.91M |
| **EBITDA** | -$209.6M | -$208.6M | -$241.6M | -$83.21M | -$64.07M | -$80.48M | -$79.92M | -$45.17M | -$27.43M | -$21.77M |
| Income Before Tax | -$155.2M | -$208.0M | -$338.8M | -$83.95M | -$65.66M | -$80.89M | -$78.25M | -- | -- | -- |
| Income Tax Expense | -$15K | $51K | -$26K | -$136K | $141K | $0 | $0 | $0 | $0 | $0 |
| **Net Income** | -$155.2M | -$208.0M | -$338.8M | -$83.81M | -$65.80M | -$80.89M | -$78.25M | -$44.35M | -$27.24M | -$21.70M |
| Basic EPS | -- | -- | -$49.12 | -$24.86 | -$25.02 | -$38.00 | -$61.25 | -$53.25 | -$45.00 | -$55.50 |
| **Diluted EPS** | -- | -- | -$49.12 | -$24.86 | -$25.02 | -$38.00 | -$61.25 | -$53.25 | -$45.00 | -$55.50 |
| Basic Shares Outstanding | -- | -- | 6.9M | 3.4M | 2.6M | 2.1M | 1.3M | 832.9K | 605.1K | 391.7K |
| Diluted Shares Outstanding | -- | -- | 6.9M | 3.4M | 2.6M | 2.1M | 1.3M | 832.9K | 605.1K | 391.7K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | -- | $0 |
| Research & Development | $89.17M | $65.50M | $60.41M | $44.64M | $45.25M | $40.15M | $41.62M | $50.48M |
| Total Operating Expenses | $105.7M | $41.64M | $45.64M | $57.17M | $56.89M | $41.94M | $53.57M | $61.25M |
| **Operating Income** | -$105.7M | -$41.64M | -$45.64M | -$57.17M | -$56.89M | -$41.94M | -$53.57M | -$61.25M |
| **EBITDA** | -- | -- | -- | -- | -- | -- | -- | -$61.25M |
| Income Before Tax | -$96.12M | -$36.20M | -$69.00M | -$62.53M | -$11.18M | -$36.72M | -$44.79M | -$56.30M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | -$15K | $1.0K |
| **Net Income** | -$96.12M | -$36.20M | -$69.00M | -$62.53M | -$11.18M | -$36.72M | -$44.77M | -$56.30M |
| **Diluted EPS** | -- | -- | -$0.74 | -- | -- | -- | -- | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $85.72M | $89.42M | $188.9M | $34.86M | $15.14M | $90.09M | $19.25M | $22.46M | $12.82M | $47.75M |
| Short-Term Investments | $670.8M | $513.7M | $150.4M | $20.85M | $77.99M | $56.18M | $52.70M | $52.05M | $37.48M | $15.75M |
| **Cash & Short-Term Investments** | $756.5M | $603.1M | $339.3M | $55.71M | $93.13M | $146.3M | $71.95M | $74.50M | $50.30M | $63.50M |
| **Total Current Assets** | $777.8M | $608.5M | $341.5M | $62.26M | $98.89M | $149.8M | $74.50M | $76.67M | $54.99M | $66.42M |
| Property, Plant & Equipment, Net | -- | -- | $0 | $3.22M | $4.55M | $5.64M | $2.38M | $1.02M | $854K | $599K |
| Other Non-Current Assets | $0 | $10K | $9.0K | $683K | $842K | $115K | $67K | $50K | $232K | $40K |
| **Total Non-Current Assets** | $0 | $10K | $331K | $8.89M | $11.04M | $11.83M | $8.68M | $1.07M | $1.09M | $639K |
| **Total Assets** | $777.8M | $608.5M | $341.9M | $71.14M | $109.9M | $161.6M | $83.18M | $77.74M | $56.08M | $67.06M |
| Accounts Payable | -- | -- | $896K | $677K | $3.32M | $2.25M | $3.15M | $663K | $389K | $168K |
| Deferred Revenue (Current) | -- | -- | $0 | $517K | $3.58M | $0 | -- | -- | $20K | $71K |
| **Total Current Liabilities** | $58.69M | $54.06M | $31.98M | $14.66M | $20.14M | $16.44M | $18.36M | $10.24M | $5.63M | $3.96M |
| Deferred Revenue (Non-Current) | -- | -- | $0 | $2.18M | $1.22M | $0 | -- | -- | -- | -- |
| Other Non-Current Liabilities | $0 | -- | -- | $0 | $16K | $214K | $31K | $72K | $111K | $132K |
| **Total Non-Current Liabilities** | $3.86M | $36.62M | $41.31M | $6.18M | $5.84M | $5.34M | $4.74M | $72K | $111K | $132K |
| **Total Liabilities** | $62.55M | $90.68M | $73.29M | $20.84M | $25.98M | $21.79M | $23.10M | $10.31M | $5.74M | $4.10M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $4.64M | $5.48M | $5.52M | $5.12M | -- | -- | -- |
| Common Stock | $15K | $13K | $10K | $6.0K | $5.0K | $5.0K | $3.0K | $2.0K | $2.0K | $1.0K |
| Retained Earnings | -$1.13B | -$972.4M | -$764.4M | -$425.6M | -$341.8M | -$276.0M | -$195.1M | -$116.9M | -$72.51M | -$45.28M |
| Accumulated Other Comp. Income | $869K | $180K | $302K | -$48K | -$20K | $11K | $51K | -$27K | -$102K | -$4.0K |
| **Total Stockholders' Equity** | $715.2M | $517.8M | $184.0M | $50.30M | $83.94M | $139.8M | $60.08M | $67.43M | $50.34M | $62.97M |
| Total Equity | $715.2M | $517.8M | $184.0M | $50.30M | $83.94M | $139.8M | $60.08M | $67.43M | $50.34M | $62.97M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $82.73M | $162.0M | $97.19M | $85.72M | $64.90M | $81.66M | $48.49M | $89.42M |
| Short-Term Investments | $989.2M | $983.3M | $644.3M | $670.8M | $421.3M | $444.9M | $516.3M | $513.7M |
| **Cash & Short-Term Investments** | $1.10B | $1.10B | $741.5M | $756.5M | $486.2M | $526.6M | $564.8M | $603.1M |
| **Total Current Assets** | $1.10B | $1.17B | $764.0M | $777.8M | $504.6M | $538.8M | $569.8M | $608.5M |
| Other Non-Current Assets | -- | -- | -- | $0 | $0 | $0 | $10K | $10K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $10K | $10K |
| **Total Assets** | $1.10B | $1.17B | $764.0M | $777.8M | $504.6M | $538.8M | $569.8M | $608.5M |
| **Total Current Liabilities** | $40.14M | $63.30M | $85.16M | $58.69M | $46.27M | $83.06M | $70.68M | $54.06M |
| Other Non-Current Liabilities | $1.29M | $1.29M | $1.29M | $0 | -- | -- | -- | -- |
| **Total Non-Current Liabilities** | $8.05M | $8.56M | $7.98M | $3.86M | $3.23M | $0 | $16.49M | $36.62M |
| **Total Liabilities** | $48.19M | $71.86M | $93.14M | $62.55M | $49.50M | $83.06M | $87.17M | $90.68M |
| Common Stock | $16K | $16K | $15K | $15K | $13K | $13K | $13K | $13K |
| Retained Earnings | -$1.33B | -$1.23B | -$1.20B | -$1.13B | -$1.07B | -$1.05B | -$1.02B | -$972.4M |
| Accumulated Other Comp. Income | -$5.38M | -$2.40M | -$767K | $869K | $791K | $454K | $682K | $180K |
| **Total Stockholders' Equity** | $1.05B | $1.10B | $670.8M | $715.2M | $455.1M | $455.8M | $482.6M | $517.8M |
| Total Equity | $1.05B | $1.10B | $670.8M | $715.2M | $455.1M | $455.8M | $482.6M | $517.8M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$155.2M | -$208.0M | -$338.8M | -$83.81M | -$65.80M | -$80.89M | -$78.25M | -$44.35M | -$27.24M | -$21.70M |
| Depreciation & Amortization | $0 | $0 | $744K | $1.57M | $1.58M | $996K | $418K | $293K | $249K | $132K |
| Stock-Based Compensation | $37.61M | $44.83M | $25.68M | $7.11M | $8.04M | $6.26M | $4.88M | $4.28M | $2.49M | $1.22M |
| Change in Receivables | $0 | $0 | $375K | $440K | -$815K | $0 | $0 | $3.08M | -$1.86M | $482K |
| Change in Payables | $8.24M | -$230K | $218K | -$2.64M | $1.06M | -$544K | $2.58M | $239K | $164K | -$8.0K |
| **Operating Cash Flow** | -$169.3M | -$157.4M | -$99.91M | -$80.14M | -$53.72M | -$75.78M | -$65.69M | -$32.19M | -$24.61M | -$18.84M |
| Capital Expenditure | -- | $0 | $0 | -$38K | -$573K | -$4.28M | -$1.49M | -$422K | -$619K | -$212K |
| **Free Cash Flow** | -- | -$157.4M | -$99.91M | -$80.18M | -$54.29M | -$80.06M | -$67.18M | -$32.62M | -$25.23M | -$19.05M |
| Purchases of Investments | -$522.2M | -$599.3M | -$166.8M | -$39.50M | -$133.1M | -$129.0M | -$91.93M | -$62.18M | -$64.11M | -$20.39M |
| **Investing Cash Flow** | -$143.5M | -$353.3M | -$108.4M | $57.01M | -$22.62M | -$7.60M | -$1.74M | -$15.23M | -$22.53M | -$12.08M |
| Common Stock Issued | -- | -- | $84.56M | $0 | $0 | -- | -- | -- | -- | $76K |
| **Financing Cash Flow** | $309.0M | $410.9M | $361.1M | $42.68M | $1.39M | $154.5M | $65.72M | $57.07M | $12.21M | $49.37M |
| **Net Change in Cash** | -$3.70M | -$99.79M | $152.8M | $19.44M | -$74.96M | $71.18M | -$1.71M | $9.64M | -$34.93M | $18.45M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$96.12M | -$36.20M | -$69.00M | -$62.53M | -$11.18M | -$36.72M | -$44.77M | -$56.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | -- | $0 |
| Stock-Based Compensation | $14.17M | $13.51M | $12.81M | $9.81M | $9.57M | $9.38M | $8.86M | $9.22M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | -- | $0 |
| Change in Payables | $3.74M | $30K | -$3.21M | $1.45M | $3.75M | $23K | $3.02M | -$4.50M |
| **Operating Cash Flow** | -$77.50M | -$69.88M | -$57.37M | -$44.58M | -$37.12M | -$46.56M | -$40.99M | -$37.20M |
| Purchases of Investments | -$138.3M | -$447.3M | -$81.17M | -$341.7M | -$74.19M | -$34.87M | -$71.44M | -$233.1M |
| **Investing Cash Flow** | -$3.80M | -$297.9M | $56.58M | -$247.4M | $25.00M | $79.00M | -$61K | -$170.5M |
| **Financing Cash Flow** | $2.02M | $432.6M | $12.26M | $312.8M | -$4.64M | $731K | $125K | $225.6M |
| **Net Change in Cash** | -$79.28M | $64.82M | $11.46M | $20.82M | -$16.76M | $33.17M | -$40.93M | $17.84M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -27348.0% | -3640.2% | -350.3% | -- | -- | -1169.3% | -531.7% | -473.3% |
| **Net Profit Margin** | -- | -- | -38238.1% | -3598.8% | -351.1% | -- | -- | -1140.6% | -523.3% | -468.8% |
| Return on Equity (ROE) | -21.7% | -40.2% | -184.1% | -166.6% | -78.4% | -57.9% | -130.2% | -65.8% | -54.1% | -34.5% |
| Return on Assets (ROA) | -20.0% | -34.2% | -99.1% | -117.8% | -59.9% | -50.1% | -94.1% | -57.0% | -48.6% | -32.4% |
| Current Ratio | 13.25x | 11.26x | 10.68x | 4.25x | 4.91x | 9.11x | 4.06x | 7.49x | 9.77x | 16.75x |
| Quick Ratio | 12.89x | 11.16x | 10.61x | 3.80x | 4.62x | 8.90x | 3.92x | 7.28x | 8.94x | 16.02x |
| Debt to Equity | -- | -- | -- | 0.09x | 0.07x | 0.04x | 0.09x | -- | -- | -- |
| **Revenue Growth (YoY)** | -- | -100.0% | -62.0% | -87.6% | -- | -- | -100.0% | -25.3% | +12.5% | -- |
| 5Y Revenue / Share Growth | -- | -- | -97.2% | -92.0% | -39.7% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -25.1% | -16.2% | -26.7% | -21.7% | -32.7% | -45.4% | -43.3% | -40.2% |
| Return on Assets (ROA) | -24.0% | -15.3% | -23.5% | -20.0% | -29.5% | -38.4% | -36.7% | -34.2% |
| Current Ratio | 27.40x | 18.53x | 8.97x | 13.25x | 10.90x | 6.49x | 8.06x | 11.26x |
| Quick Ratio | 27.40x | 17.38x | 8.71x | 12.89x | 10.51x | 6.34x | 7.99x | 11.16x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
